How should I manage a patient with established liver cirrhosis?

Management of Liver Cirrhosis

First-line management of cirrhosis centers on treating the underlying etiology, implementing sodium restriction (88 mmol/day or 2000 mg/day), and initiating diuretic therapy with oral spironolactone (starting 100 mg daily) combined with furosemide (starting 40 mg daily) for patients who develop ascites. 1, 2, 1

Etiological Treatment

Addressing the underlying cause is paramount and can prevent decompensation or even achieve recompensation:

• Alcohol-related cirrhosis: Absolute abstinence is mandatory. Patients with Child-Pugh C cirrhosis who stop drinking have approximately 75% 3-year survival, while those who continue drinking have 0% survival at 3 years 1
• Hepatitis B: Antiviral therapy improves outcomes in decompensated patients 3
• Hepatitis C: Direct antiviral agents improve liver function and portal hypertension, though benefits vary 3
• NAFLD/NASH: Weight loss is the priority—greater weight loss correlates with greater liver benefit. Target weight reduction through dietary modification (reducing saturated fat, starch, and added sugars), exercise (aerobic 30-60 min 3-5 days/week plus resistance training 2-3 times/week), and consider anti-obesity medications or bariatric surgery 4

Ascites Management Algorithm

Initial Presentation with Ascites

1. Diagnostic paracentesis is mandatory at first presentation to determine SAAG (serum-ascites albumin gradient), check cell count for infection, and rule out alternative causes 1

2. For tense ascites: Perform initial large-volume paracentesis (LVP) to rapidly relieve symptoms, then initiate sodium restriction and diuretics 1, 2

   • If removing >5L, administer albumin 8g per liter removed 1
   • Single 5L paracentesis can be done safely without albumin 1

3. Sodium restriction: Limit to 88 mmol/day (2000 mg/day, approximately 1 teaspoon) 1, 2, 1

   • Patients must read food labels to track intake 5

4. Fluid restriction: Only necessary if serum sodium <120-125 mmol/L 1, 2, 1

Diuretic Therapy

Start with combination therapy:

• Spironolactone 100 mg once daily PLUS furosemide 40 mg once daily 1, 2, 1
• Titrate upward every 3-5 days until achieving natriuresis and weight loss
• Maximum doses: spironolactone 400 mg/day, furosemide 160 mg/day 2

Monitoring during diuresis:

• Target weight loss: 0.5 kg/day without peripheral edema, up to 1 kg/day with edema
• Monitor electrolytes, renal function, and mental status
• Stop diuretics if: creatinine >2.0 mg/dL, sodium <120 mmol/L, potassium >6.0 mmol/L, or encephalopathy develops 1, 2

Avoid NSAIDs completely—they reduce urinary sodium excretion and can convert diuretic-sensitive patients to refractory 1, 2

Refractory Ascites

Definition: Ascites unresponsive to maximum diuretics (400 mg spironolactone + 160 mg furosemide) with sodium restriction, OR rapid recurrence after therapeutic paracentesis 1, 2

Management options in order of preference:

1. Serial large-volume paracentesis every 2-3 weeks as needed 1, 2

   • Administer albumin 8g/L removed if >5L 1

2. TIPSS (transjugular intrahepatic portosystemic shunt): Consider in appropriate candidates 2

3. Liver transplantation evaluation: Should be initiated when ascites develops, as this marks decompensation with poor prognosis 1, 2

4. Automated low-flow ascites pumps: Only in special circumstances with robust clinical governance 5

5. Palliative care referral: For patients with refractory ascites not undergoing transplant evaluation 5, 6

Infection Prophylaxis and Treatment

Spontaneous bacterial peritonitis (SBP) surveillance:

• Perform diagnostic paracentesis at every hospital admission 1
• SBP diagnosis: PMN count ≥250 cells/mm³ 1

Treatment when PMN ≥250 cells/mm³:

• Empiric antibiotics immediately—do not wait for culture results 1
• Ceftriaxone 1g IV daily for 7 days is first-line for advanced cirrhosis, patients on quinolone prophylaxis, or settings with quinolone resistance 3
• Oral norfloxacin 400 mg twice daily for less advanced disease 3

Secondary prophylaxis after SBP:

• Long-term antibiotics to prevent recurrence 5, 3

Variceal Bleeding Management

Acute variceal hemorrhage protocol:

1. Resuscitation: Restrictive transfusion strategy with hemoglobin target 7-9 g/dL 3

2. Antibiotic prophylaxis: Start immediately on presentation

   • Ceftriaxone 1g/24h for 7 days (first-line) 3
   • Reduces infection, improves bleeding control, and improves survival 3

3. Vasoactive drugs: Initiate immediately, before endoscopy 3

4. Endoscopy: Within 12 hours to confirm diagnosis and perform endoscopic band ligation (EBL) 3

   • Consider erythromycin 250 mg IV 30-120 minutes before endoscopy to improve visibility 3

5. Avoid: Beta-blockers, vasodilators, NSAIDs, large-volume paracentesis, and nephrotoxic drugs during acute bleeding 3

Primary prophylaxis for varices:

• All cirrhotic patients need screening endoscopy at diagnosis 7
• Grade 3 varices: Start propranolol 40 mg twice daily, titrate to 80 mg twice daily (or long-acting 80-160 mg daily) 7
• Goal: Reduce hepatic venous pressure gradient to <12 mm Hg 7
• If propranolol contraindicated: Variceal band ligation 7

Hepatorenal Syndrome

Type 1 HRS treatment:

• Albumin 10-20g IV daily PLUS octreotide (target 200 mcg SC three times daily) PLUS midodrine (titrate to 12.5 mg PO three times daily) 1
• Goal: Increase mean arterial pressure by 15 mm Hg 1
• Can be administered outside ICU 1

Expedited liver transplant referral for all patients with Type 1 HRS 1

Critical Monitoring Parameters

Outpatient follow-up:

• Patients responding to therapy: Every 2-4 weeks initially, then every few months 1
• Early post-discharge: Within 1 week of hospital discharge 1
• Monitor: Weight, sodium intake compliance, urinary sodium excretion, electrolytes, renal function, mental status

Liver Transplantation

Referral timing: Consider transplant evaluation when ascites develops, as this represents decompensation with significantly reduced survival 1, 2, 3

Palliative care is NOT mutually exclusive with transplant listing—both should be offered to patients with ACLF or critical illness 6

Common Pitfalls to Avoid

• Never restrict fluids unless sodium <120-125 mmol/L 1, 2, 1
• Never use NSAIDs in cirrhotic patients with ascites 1, 2
• Never delay paracentesis at hospital admission—infection must be ruled out 1
• Never use diuretics alone for tense ascites—perform initial LVP first 1, 2
• Never continue alcohol consumption—this is the single most important reversible factor 1
• Never delay transplant evaluation once decompensation occurs 1, 2